EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular mechanisms, functional diversity, and therapeutic implications of HSP90 isoforms in lung cancer

K P Janani, S K Lalithammbika, P K Praveen Kumar

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-13089-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 29.10.2026. Verfasst von K P Janani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Sri Venkateswara College of Engineering, Pennalur, Tamil Nadu, 602117, Sriperumbudur Tk, India. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Lung Neoplasms. Die Arbeit nennt 98 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heat shock protein 90 (HSP90) is a critical molecular chaperone that ensures the stability and maturation of oncogenic client proteins in lung cancer. This review examines the distinct roles of HSP90α, HSP90β, GRP94 and the mitochondrial paralog TRAP1 in driving disease progression. While HSP90α governs invasiveness and metastasis, HSP90β maintains homeostatic oncogenic signalling. TRAP1 serves as a metabolic lynchpin, facilitating metabolic reprogramming, mitochondrial cytoprotection, and resistance to apoptosis. Together, these isoforms stabilize key drivers such as EGFR, ALK and KRAS, fostering therapeutic resistance. Utilizing systems biology, bioinformatics and comparative analysis of experimental studies, this review explores the high-throughput identification of HSP90 isoforms as central "hub genes" within the lung cancer interactome. The therapeutic potential of mitochondrial-targeted drug delivery systems and isoform-selective inhibitors designed to minimize systemic toxicity are explored in detail. Ultimately, understanding isoform-specific dynamics and multi-omics regulatory networks is essential for developing personalized, selective interventions to overcome drug resistance and improve lung cancer management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HSP90 Heat-Shock ProteinsLung NeoplasmsHumansProtein IsoformsMitochondriaAnimalsSignal TransductionGene Expression Regulation, NeoplasticDrug Resistance, Neoplasm

Stichwörter der Autor:innen

HSP90 IsoformsMitochondrial-targeted drug deliveryMulti-omicsTRAP1

Substanzen

HSP90 Heat-Shock ProteinsProtein IsoformsTRAP1 protein, human

Autor:innen und Institutionen

  • Department of Biotechnology, Sri Venkateswara College of Engineering, Pennalur, Tamil Nadu, 602117, Sriperumbudur Tk, India.
  • Department of Biotechnology, Sri Venkateswara College of Engineering, Pennalur, Tamil Nadu, 602117, Sriperumbudur Tk, India. praveenpk@svce.ac.in.
  • Phytonanos Drug Technologies Pvt. Ltd, Chennai, 600073, Tamil Nadu, India. praveenpk@svce.ac.in.

Zitieren

APA

Janani, K. P., Lalithammbika, S. K., & Praveen Kumar, P. K. (2026). Molecular mechanisms, functional diversity, and therapeutic implications of HSP90 isoforms in lung cancer. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-13089-8

Vancouver

Janani KP, Lalithammbika SK, Praveen Kumar PK. Molecular mechanisms, functional diversity, and therapeutic implications of HSP90 isoforms in lung cancer. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-13089-8

BibTeX
@article{Janani2026,
  author = {Janani, K P and Lalithammbika, S K and Praveen Kumar, P K},
  title = {Molecular mechanisms, functional diversity, and therapeutic implications of HSP90 isoforms in lung cancer},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-13089-8}
}
Kostenlos starten →